Company / Total Debt
Krystal Biotech, Inc. Total Debt History
FY2017-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$4.3M
FY2017
5-year range
-
FY2017-FY2017
Trend
-
vs FY2016
Sector context
#79 of 83
Health Care
What the data says
Among 83 Health Care companies, Krystal Biotech, Inc. is in the top 5% for total debt.
Based on SEC 10-K filings.
$4M in FY2017.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 83This company $4.3M Sector average $6.2B
▼
-99.9% below sector average
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $4.3M | - |
| FY2016 | - | - |
As of FY2017 · SEC 10-K · Updated Feb 28, 2026